Bronchoalveolar lavage fluid cytokine profiles in neuroendocrine cell hyperplasia of infancy and follicular bronchiolitis

Orphanet Journal of Rare Diseases

Volumn 8, Issue 1, 2013, Pages

  Popler, Jonathan ^a,c   Wagner, Brandie D ^b   Tarro, Heidi Luckey ^c   Accurso, Frank J ^c   Deterding, Robin R ^c  

^a Georgia Pediatric Pulmonology Associates   (United States)

^b Food Science and Human Nutrition   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Bronchoalveolar lavage cytokine profiles; Children's interstitial lung disease (chILD); Pediatric diffuse lung disease; Pediatric interstitial lung disease

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; BRONCHIOLITIS; CELL HYPERPLASIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; EPITHELIUM CELL; ERYTHROCYTE COUNT; FEMALE; FOLLICULAR BRONCHIOLITIS; HUMAN; INFANT; INTERSTITIAL LUNG DISEASE; LEUKOCYTE COUNT; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG LAVAGE; MACROPHAGE; MALE; NEUROENDOCRINE CELL HYPERPLASIA OF INFANCY; NEUTROPHIL COUNT; PRESCHOOL CHILD; RESPIRATORY TRACT INFLAMMATION; SCHOOL CHILD;

BRONCHIOLITIS; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LEUKOCYTES; MALE; NEUROENDOCRINE CELLS; NEUTROPHILS;

EID: 84887328863     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-8-175     Document Type: Article

References (29)

1. Pediatric interstitial lung disease revisited. Fan LL, Deterding RR, Langston C, Pediatr Pulmonol 2004 38 5 369 378 10.1002/ppul.20114 15376335
2. Diffuse lung disease in young children: application of a novel classification scheme. Deutsch GH, Young LR, Deterding RR, et al. Am J Respir Crit Care Med 2007 176 11 1120 1128 10.1164/rccm.200703-393OC 17885266
3. Genetic basis of children's interstitial lung disease. Nogee LM, Pediatr Allergy Immunol Pulmonol 2010 23 1 15 24 10.1089/ped.2009.0024 22087432
4. Neuroendocrine cell hyperplasia of infancy: a prospective follow-up of nine children. Lukkarinen H, Peklonen A, Lohi J, Malstrom K, Malmberg LP, Kajosaari M, Lindahl H, Fohr A, Ruuskanen O, Makela MJ, Arch Dis Child 2013 98 2 141 144 10.1136/archdischild-2012-302115 23161905
5. Infants and young children with children's interstitial lung disease. Deterding RR, Pediatr Allergy Immunol Pulmonol 2010 23 1 25 31 10.1089/ped.2010.0011 22332029
6. Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia. Deterding RR, Pye C, Fan LL, Langston C, Pediatr Pulmonol 2005 40 2 157 165 10.1002/ppul.20243 15965897
7. Persistent tachypnea of infancy (PTI) - a new entity. Deterding RR, Fan LL, Morton R, Hay TC, Langston C, Pediatr Pulmonol 2001 Suppl 23 72 73 11886155
8. Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancy. Kerby GS, Wagner B, Popler J, Hay T, Kopecky C, Wilcox SL, Quinones RR, Giller RH, Accurso FJ, Deterding RR, Pediatr Pulmonol 2012 doi:10.1002/ppul.22718. [Epub ahead of print]
9. Neuroendocrine cell distribution and frequency distinguish neuroendocrine cell hyperplasia of infancy from other pulmonary disorders. Young LR, Brody AS, Inge TH, et al. Chest 2011 139 5 1060 1071 10.1378/chest.10-1304 20884725
10. Neuroendocrine cell hyperplasia of infancy: diagnosis with high-resolution CT. Brody AS, Guillerman RP, Hay TC, et al. AJR Am J Roentgenol 2010 194 1 238 244 10.2214/AJR.09.2743 20028928
11. Imaging considerations: interstitial lung disease in children. Brody AS, Radiol Clin North Am 2005 43 2 391 403 10.1016/j.rcl.2004.12.002 15737375
12. Familial neuroendocrine cell hyperplasia of infancy. Popler J, Gower WA, Mogayzel PJ Jr, et al. Pediatr Pulmonol 2010 45 8 749 755 10.1002/ppul.21219 20623780
13. Follicular bronchitis in the pediatric population. Kinane BT, Mansell AL, Zwerdling RG, Lapey A, Shannon DC, Chest 1993 104 4 1183 1186 10.1378/chest.104.4.1183 8404188
14. Bronchoalveolar lavage in idiopathic interstitial lung diseases. Nagai S, Handa T, Ito Y, Takeuchi M, Izumi T, Semin Respir Crit Care Med 2007 28 5 496 503 10.1055/s-2007-991522 17975777
15. Persistent wheezing in very young children is associated with lower respiratory inflammation. Krawiec ME, Westcott JY, Chu HW, et al. Am J Respir Crit Care Med 2001 163 6 1338 1343 10.1164/ajrccm.163.6.2005116 11371398
16. Bronchoalveolar lavage in children. ERS task force on bronchoalveolar lavage in children. European respiratory society. de Blic J, Midulla F, Barbato A, et al. Eur Respir J 2000 15 1 217 231 10.1183/09031936.00.15121700 10678650
17. An official American thoracic society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Meyer KC, Raghu G, Baughman RP, et al. Am J Respir Crit Care Med 2012 185 9 1004 1014 10.1164/rccm.201202-0320ST 22550210
18. Infant pulmonary function testing in children with neuroendocrine cell hyperplasia with and without lung biopsy. Kerby GS, Kopecky C, Wilcox SL, et al. Am J Respir Crit Care Med 2009 179 3671
19. Interstitial lung disease in children older than 2 years. Vece TJ, Fan LL, Pediatr Allergy Immunol Pulmonol 2010 23 33 41 10.1089/ped.2010.0008 22332030
20. Pulmonary neuroendocrine cells and neuroepithelial bodies in sudden infant death syndrome: potential markers of airway chemoreceptor dysfunction. Cutz E, Perrin DG, Pan J, Haas EA, Krous HF, Pediatr Dev Pathol 2007 10 2 106 116 10.2350/06-06-0113.1 17378691
21. Pulmonary neuroepithelial bodies as airway sensors: putative role in the generation of dyspnea. Domnik NJ, Cutz E, Curr Opin Pharmacol 2011 11 3 211 217 10.1016/j.coph.2011.04.003 21530400
22. Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias. Ryu YJ, Chung MP, Han J, et al. Respir Med 2007 101 3 655 660 10.1016/j.rmed.2006.06.003 16919929
23. Bronchoalveolar lavage in other interstitial lung diseases. Costabel U, Guzman J, Bonella F, Oshimo S, Semin Respir Crit Care Med 2007 28 5 514 524 10.1055/s-2007-991525 17975779
24. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases. Vasakova M, Sterclova M, Kolesar L, et al. Scand J Immunol 2009 69 3 268 274 10.1111/j.1365-3083.2008.02222.x 19281539
25. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Richards TJ, Kaminski N, Baribaud F, et al. Am J Respir Crit Care Med 2012 185 1 67 76 10.1164/rccm.201101-0058OC 22016448
26. Serum KL-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism. Doan ML, Elidemir O, Dishop MK, et al. Thorax 2009 64 8 677 681 10.1136/thx.2008.107979 19237389
27. Immunology mini-review: the basics of T(H)17 and interleukin-6 in transplantation. Nakagiri T, Inoue M, Minami M, Shintani Y, Okumura M, Transplant Proc 2012 44 4 1035 1040 10.1016/j.transproceed.2011.12.032 22564619
28. Sputum biomarkers of inflammation in cystic fibrosis lung disease. Sagel SD, Chmiel JF, Konstan MW, Proc Am Thorac Soc 2007 4 4 406 417 10.1513/pats.200703-044BR 17652508
29. Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis. Brennan S, Sly PD, Gangell CL, et al. Eur Respir J 2009 34 3 655 661 10.1183/09031936.00178508 19386685